We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Tom Brassington


Tom Brassington

Tom is a leading partner in the firm's London corporate practice. He combines commercial acumen with transaction efficiency to ensure the best possible outcome for his clients. He is ranked in Chambers for High-end Corporate and M&A, his knowledge in cross border M&A is highlighted in particular. He was also recently considered a 'Corporate Rising Star' in the London market by Legal Business magazine.

He has experience across a wide variety of work including public and private M&A, joint ventures, restructurings, private equity and equity capital markets. Whilst Tom is a generalist M&A practitioner, he regularly acts for clients in the Life Sciences and TMT sectors. Much of Tom's work has a cross-border or international focus. Whilst Tom is based in London, he has also practiced in both Dubai and Hong Kong.

'commercial in his attitude, view and outlook.'

Chambers UK

Representative Experience

Advising News Corporation on the acquisitions of Shine and Unruly.

Advising Google on a variety of corporate transactions in the UK.

Advising Jazz Pharmaceuticals PLC on the sale of a portfolio of pharmaceutical products and medical devices to Essex Woodlands Fund IX L.P.

Advising Johnson and Johnson on transactions including acquisitions of Spectrum Vision; OTC brands of JB Chemicals & Pharmaceuticals Limited; and Finsbury Orthopaedics on business disposal.

Advising Bestway Group on the acquisition of the Co-operative Group's Pharmacy business for £620m.

Advising Ares Capital on its participation in a debt-for-equity swap and placing, and then subsequent take private, of Healthcare Locums plc.

Advising RBC Capital Markets as sponsor to Petra Diamonds Limited's admission to the Official List and to trading on the Main Market of the LSE.

Advising Moor Park on the £700m sale and leaseback of 12 Spire Healthcare hospitals.

Education and admissions


  • The University of Nottingham


  • Law Society
Loading data